Literature DB >> 35304658

Correction to: Complement in ischaemia-reperfusion injury and transplantation.

Mark C Howard1, Christopher L Nauser2, Conrad A Farrar2, Steven H Sacks2.   

Abstract

Entities:  

Year:  2022        PMID: 35304658      PMCID: PMC9064847          DOI: 10.1007/s00281-022-00924-w

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   11.759


× No keyword cloud information.
Correction to: Seminars in Immunopathology (2021) 43:789-797 10.1007/s00281-021-00896-3 The order of Reference 78–85 were incorrect. Here is the correct information:
  5 in total

1.  Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Peter Hillmen; Jeff Szer; Ilene Weitz; Alexander Röth; Britta Höchsmann; Jens Panse; Kensuke Usuki; Morag Griffin; Jean-Jacques Kiladjian; Carlos de Castro; Hisakazu Nishimori; Lisa Tan; Mohamed Hamdani; Pascal Deschatelets; Cedric Francois; Federico Grossi; Temitayo Ajayi; Antonio Risitano; Régis Peffault de la Tour
Journal:  N Engl J Med       Date:  2021-03-18       Impact factor: 91.245

Review 2.  Rationale for targeting complement in COVID-19.

Authors:  Anastasia Polycarpou; Mark Howard; Conrad A Farrar; Roseanna Greenlaw; Giorgia Fanelli; Russell Wallis; Linda S Klavinskis; Steven Sacks
Journal:  EMBO Mol Med       Date:  2020-07-12       Impact factor: 12.137

Review 3.  Therapeutic Modulation of the Complement System in Kidney Transplantation: Clinical Indications and Emerging Drug Leads.

Authors:  Vasishta S Tatapudi; Robert A Montgomery
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

4.  AKI in Hospitalized Patients with COVID-19.

Authors:  Lili Chan; Kumardeep Chaudhary; Aparna Saha; Kinsuk Chauhan; Akhil Vaid; Shan Zhao; Ishan Paranjpe; Sulaiman Somani; Felix Richter; Riccardo Miotto; Anuradha Lala; Arash Kia; Prem Timsina; Li Li; Robert Freeman; Rong Chen; Jagat Narula; Allan C Just; Carol Horowitz; Zahi Fayad; Carlos Cordon-Cardo; Eric Schadt; Matthew A Levin; David L Reich; Valentin Fuster; Barbara Murphy; John C He; Alexander W Charney; Erwin P Böttinger; Benjamin S Glicksberg; Steven G Coca; Girish N Nadkarni
Journal:  J Am Soc Nephrol       Date:  2020-09-03       Impact factor: 10.121

5.  Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria

Authors:  Antonio M Risitano; Austin G Kulasekararaj; Jong Wook Lee; Jaroslaw P Maciejewski; Rosario Notaro; Robert Brodsky; Mingjun Huang; Michael Geffner; Peter Browett
Journal:  Haematologica       Date:  2021-12-01       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.